Comparison of exhaled breath condensate pH using two commercially available devices in healthy controls, asthma and COPD patients.
about
A Review of Analytical Techniques and Their Application in Disease Diagnosis in Breathomics and Salivaomics ResearchExhaled Breath Condensate: Technical and Diagnostic AspectsComparison of two devices and two breathing patterns for exhaled breath condensate samplingRandomized controlled trial of fish oil and montelukast and their combination on airway inflammation and hyperpnea-induced bronchoconstrictionDASH for asthma: a pilot study of the DASH diet in not-well-controlled adult asthma.Association of Lung Inflammatory Cells with Small Airways Function and Exhaled Breath Markers in Smokers - Is There a Specific Role for Mast Cells?A mobile instrumentation platform to distinguish airway disorders.The degradation of airway tight junction protein under acidic conditions is probably mediated by transient receptor potential vanilloid 1 receptor.pH in exhaled breath condensate and nasal lavage as a biomarker of air pollution-related inflammation in street traffic-controllers and office-workers.Bronchoalveolar pH and inflammatory biomarkers in newly diagnosed IPF and GERD patients: a case-control study.Isoprostanes-biomarkers of lipid peroxidation: their utility in evaluating oxidative stress and analysis.Transient receptor potential vanilloid 1 receptors mediate acid-induced mucin secretion via Ca2+ influx in human airway epithelial cells.Exhaled Breath Condensate pH in Lung Cancer, the Impact of Clinical Factors.Exhaled breath condensate pH in patients with cystic fibrosis.Effects of exercise on secretion transport, inflammation, and quality of life in patients with noncystic fibrosis bronchiectasis: Protocol for a randomized controlled trial.Changes in exhaled breath condensate pH in healthy and asthmatic pregnant women.
P2860
Q28069683-4E8A2829-45A9-4AB9-B7FC-5CF3AA9E6585Q28082250-03521E3F-16A1-4ED7-BF07-58E47F749E5FQ28477844-C72E4755-B4D4-4DE7-A02C-9E2BF7821C57Q33728401-B4CAB067-61A1-4440-9B3B-B754B5873458Q34442674-36220581-63F8-4BAD-ACE3-AC5324AB3A68Q35662236-8FA31141-BFA7-4F83-9B2A-F3A9264930AEQ36787683-3C2C4AE7-567F-405C-AA60-B5C65E884C45Q37270350-FF025FF3-ADDB-4E9E-8EDD-5AACCB9EF2CCQ37342490-DB6B1CA9-1A0C-49D6-BF79-3082F5793548Q37595637-B8A8CE05-FE45-4AC2-9B53-7306E41A6486Q37820124-1D79C223-E6DA-456A-A4B9-05E4F659D6FAQ39352196-06256C0D-6937-4748-AD2D-7528CD8C21F3Q41495367-8C2C936E-B1E1-40AA-9A35-A71CE0D05566Q44474413-4F42AB23-023B-4DFF-9086-DB19E4094CC9Q50003410-B5B9E20D-D577-492F-AFA8-73B03BF40678Q50875582-9410F7E8-7DDC-4EA0-9FA2-25E325FA99D5
P2860
Comparison of exhaled breath condensate pH using two commercially available devices in healthy controls, asthma and COPD patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 August 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Comparison of exhaled breath c ...... ols, asthma and COPD patients.
@en
Comparison of exhaled breath c ...... ols, asthma and COPD patients.
@nl
type
label
Comparison of exhaled breath c ...... ols, asthma and COPD patients.
@en
Comparison of exhaled breath c ...... ols, asthma and COPD patients.
@nl
prefLabel
Comparison of exhaled breath c ...... ols, asthma and COPD patients.
@en
Comparison of exhaled breath c ...... ols, asthma and COPD patients.
@nl
P2093
P2860
P921
P356
P1433
P1476
Comparison of exhaled breath c ...... ols, asthma and COPD patients.
@en
P2093
Klaus F Rabe
Peter J Sterk
Pieter S Hiemstra
Rembert Koczulla
Robert Bals
Robert Schot
Silvano Dragonieri
Stefanie A Gauw
P2860
P2888
P356
10.1186/1465-9921-10-78
P577
2009-08-24T00:00:00Z
P5875
P6179
1019962392